Inovio Pharmaceuticals SG&A Expense (Quarterly) Insights

Inovio Pharmaceuticals Inc (INO)

10.52 +0.52 (+5.20%) USD | NASDAQ | Apr 23, 11:24

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1998. Upgrade now.

Date	Value
December 31, 2023	10.24M
September 30, 2023	9.925M
June 30, 2023	13.52M
March 31, 2023	13.89M
December 31, 2022	13.95M
September 30, 2022	11.82M
June 30, 2022	48.46M
March 31, 2022	15.95M
December 31, 2021	14.05M
September 30, 2021	13.16M
June 30, 2021	12.67M
March 31, 2021	13.88M
December 31, 2020	8.618M
September 30, 2020	10.11M
June 30, 2020	11.07M
March 31, 2020	7.448M
December 31, 2019	8.697M
September 30, 2019	5.681M
June 30, 2019	5.850M
March 31, 2019	6.975M
December 31, 2018	5.636M
September 30, 2018	6.792M
June 30, 2018	7.189M
March 31, 2018	9.698M
December 31, 2017	8.034M

Date	Value
September 30, 2017	6.320M
June 30, 2017	6.169M
March 31, 2017	7.768M
December 31, 2016	6.966M
September 30, 2016	5.756M
June 30, 2016	5.800M
March 31, 2016	5.372M
December 31, 2015	4.860M
September 30, 2015	4.378M
June 30, 2015	4.718M
March 31, 2015	4.108M
December 31, 2014	4.224M
September 30, 2014	3.154M
June 30, 2014	4.347M
March 31, 2014	4.132M
December 31, 2013	4.340M
September 30, 2013	3.283M
June 30, 2013	3.047M
March 31, 2013	2.974M
December 31, 2012	2.919M
September 30, 2012	2.674M
June 30, 2012	2.697M
March 31, 2012	2.488M
December 31, 2011	3.254M
September 30, 2011	2.323M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

5.681M

Minimum

Sep 2019

48.46M

Maximum

Jun 2022

13.10M

Average

11.82M

Median

Sep 2022

SG&A Expense (Quarterly) Benchmarks